Feb 27 Watch 5:50 J&J vaccine: Fight against COVID-19 gets another shot in the arm By PBS NewsHour Vaccination efforts to fight the pandemic got another shot in the arm. The Johnson & Johnson vaccine, which is expected to rollout soon after the FDA nod, will speed up inoculations against COVID-19, but it might be a while before… Continue watching
Feb 26 FDA advisory panel endorses single-shot COVID-19 vaccine from Johnson & Johnson By Lauren Neergaard, Matthew Perrone, Associated Press The FDA is expected to quickly follow the recommendation and make J&J's shot the third vaccine authorized for emergency use in the U.S. Shipments of a few million doses could begin as early as Monday. Continue reading
Feb 26 How does the Johnson & Johnson vaccine compare to other coronavirus vaccines? By Maureen Ferran, The Conversation The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to global vaccination efforts. Continue reading
Feb 26 WATCH: FDA committee endorses emergency use for Johnson & Johnson COVID-19 vaccine By Associated Press If granted emergency use, Johnson & Johnson's vaccine would be the third available vaccine in the United States, but the first to require one dose rather than two. Continue reading
Feb 24 FDA says Johnson & Johnson’s single-dose shot protects against COVID-19 By Lauren Neergaard, Matthew Perrone, Associated Press An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine provides strong protection against severe COVID-19. Continue reading
Feb 04 Johnson & Johnson asks U.S. regulators to approve its one-shot COVID-19 vaccine By Lauren Neergaard, Associated Press Preliminary results from a massive study showed J&J's vaccine was safe and offered strong protection against moderate to severe COVID-19. Continue reading
Jan 29 Johnson & Johnson’ single-shot vaccine is 66 percent effective against COVID-19 By Lauren Neergaard and Linda A. Johnson, Associated Press With vaccinations off to a rocky start globally, experts had been counting on a one-dose vaccine that would stretch scarce supplies and avoid the logistics nightmare of getting people to return for boosters. Continue reading
Oct 23 AstraZeneca, Johnson & Johnson resume U.S. tests of COVID-19 vaccines By Linda A. Johnson, Associated Press Two drugmakers say they have the go-ahead to resuming U.S. testing of their COVID-19 vaccine candidates. Both are in the final stage of testing before the companies can seek regulatory approval. Continue reading
Sep 23 Late-stage study of first single-shot vaccine begins in U.S. By Linda A. Johnson, Associated Press Johnson & Johnson is beginning a huge final-stage study to try to prove if a single-dose COVID-19 vaccine can protect against the virus. Continue reading
Nov 15 Oklahoma judge reduces J&J order in opioid lawsuit by $107 million By Sean Murphy, Ken Miller, Associated Press An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis on Friday reduced that amount by $107 million in a final order in the case. Continue reading